<i>Notes From the Field:</i> Prevalence of Previous Dengue Virus Infection Among Children and Adolescents — U.S. Virgin Islands, 2022
Valerie Mac, Laura E. Adams(Centers for Disease Control and Prevention), Zula Battiste, Anna C. Fagre(Iowa State University), Joshua M. Wong(Centers for Disease Control and Prevention), Janelle Rossington, Mark Delorey, Shanice Battle, Hannah G. Rosenblum(National Center for Immunization and Respiratory Diseases), Hannah R. Volkman, Gabriela Paz‐Bailey(Centers for Disease Control and Prevention), Jessica Meeker, Briana Lettsome, Brad J. Biggerstaff, Annellie Gumbs, Brian S. Wakeman, Brett R. Ellis, Aubrey Drummond, Niurka Hernandez, Valentine Wanga(Applied Materials (United States)), Winifred Powell, Patricia Charles, Joseph Roth, Freddy A. Medina(Centers for Disease Control and Prevention), Raymond Soto, Jamaal Carroll, Wilfredo Valentin, Janice Pérez‐Padilla, Brenae Zimmerman, Monifa Carrillo, Julia Janssen, Esther M. Ellis, Marlon Lawrence, Stephen M. Bart, Lisa LaPlace Ekpo, Rafael Tosado
Cited by 5
Related Papers
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
|Preventing Chronic Disease|2021|370
All-Optical Network Consortium-ultrafast TDM networks
|IEEE Journal on Selected Areas in Communications|1996|358
Dengue
|The Lancet|2024|264
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
|MMWR Morbidity and Mortality Weekly Report|2021|215